New Jersey Federal Judge: Teva ‘ProAir’ Patents Improperly Listed
TRENTON, N.J. — Five patents listed by Teva Pharmaceuticals Inc. with the U.S. Food and Drug Administration in connection with a new drug application (NDA) for ProAir HFA (albuterol sulfate) Inhalation...To view the full article, register now.
Already a subscriber? Click here to view full article